United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 23, 2026 · Filed Apr 24, 2026

On Apr 23, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$572.35 for US$5.44M under a trading plan, leaving 40,513 shares. Filed Apr 24, 2026 (Form 4).

Sold
9,500 shares
Price
US$572.35 average (US$569.62 to US$576.33)
Value
US$5.44M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 23, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 23, 2026Common StockSale245US$569.6249,768Direct
Apr 23, 2026Common StockSale1,055US$570.7648,713Direct
Apr 23, 2026Common StockSale2,921US$571.5945,792Direct
Apr 23, 2026Common StockSale3,688US$572.6042,104Direct
Apr 23, 2026Common StockSale567US$573.3841,537Direct
Apr 23, 2026Common StockSale521US$574.7141,016Direct
Apr 23, 2026Common StockSale143US$575.2640,873Direct
Apr 23, 2026Common StockSale360US$576.3340,513Direct

Source

View original at SEC

Related